Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 1
1967 1
1970 1
1973 1
1974 2
1979 2
1980 7
1981 8
1982 12
1983 18
1984 12
1985 12
1986 9
1987 9
1988 25
1989 16
1990 21
1991 18
1992 24
1993 20
1994 16
1995 9
1996 19
1997 31
1998 33
1999 22
2000 29
2001 33
2002 39
2003 34
2004 30
2005 28
2006 31
2007 26
2008 27
2009 15
2010 25
2011 35
2012 51
2013 40
2014 41
2015 35
2016 54
2017 45
2018 37
2019 44
2020 55
2021 54
2022 49
2023 52
2024 49
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,240 results

Results by year

Filters applied: . Clear all
Page 1
[Aquaporin-4].
Tani K, Hiroaki Y, Fujiyoshi Y. Tani K, et al. Rinsho Shinkeigaku. 2008 Nov;48(11):941-4. doi: 10.5692/clinicalneurol.48.941. Rinsho Shinkeigaku. 2008. PMID: 19198125 Review. Japanese.
Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.
Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, Masubuchi T, Matsuki T, Tani K, Osamura RY, Hirai H, Yamada S, Kawakita D, Miura K, Kamata SE, Nagao T. Takahashi H, et al. Among authors: tani k. J Clin Oncol. 2019 Jan 10;37(2):125-134. doi: 10.1200/JCO.18.00545. Epub 2018 Nov 19. J Clin Oncol. 2019. PMID: 30452336 Clinical Trial.
[Oncolytic coxsackievirus therapy as an immunostimulator].
Miyamoto S, Sagara M, Kohara H, Tani K. Miyamoto S, et al. Among authors: tani k. Rinsho Ketsueki. 2017;58(8):977-982. doi: 10.11406/rinketsu.58.977. Rinsho Ketsueki. 2017. PMID: 28883283 Review. Japanese.
4,4'-Dichloro-2,2'-(piperazine-1,4-diyldimethyl-ene)diphenol.
Kubono K, Tsuno Y, Tani K, Yokoi K. Kubono K, et al. Among authors: tani k. Acta Crystallogr Sect E Struct Rep Online. 2008 Nov 13;64(Pt 12):o2309. doi: 10.1107/S1600536808035769. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21581286 Free PMC article.
[Genetic diagnosis of intestinal cancer].
Yoshimura K, Oka M, Tani K. Yoshimura K, et al. Among authors: tani k. Nihon Rinsho. 2010 Aug;68 Suppl 8:451-7. Nihon Rinsho. 2010. PMID: 20976922 Review. Japanese. No abstract available.
Di-μ(2)-acetato-1:2κ(2)O:O';2:3κ(2)O:O'-bis-{μ(2)-4,4'-dichloro-2,2'-[2,2-dimethyl-propane-1,3-diylbis(nitrilo-methanylyl-idene)]diphenolato}-1:2κ(6)O,N,N',O':O,O';2:3κ(6)O,O':O,N,N',O'-tricopper(II).
Kubono K, Tani K, Yokoi K. Kubono K, et al. Among authors: tani k. Acta Crystallogr Sect E Struct Rep Online. 2012 Nov 1;68(Pt 11):m1430-1. doi: 10.1107/S1600536812044315. Epub 2012 Oct 31. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 23284391 Free PMC article.
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.
Kawakita D, Nagao T, Takahashi H, Kano S, Honma Y, Hirai H, Saigusa N, Akazawa K, Tani K, Ojiri H, Tsukahara K, Ozawa H, Okami K, Kondo T, Togashi T, Fushimi C, Shimura T, Shimizu A, Okamoto I, Okada T, Imanishi Y, Watanabe Y, Otsuka K, Sakai A, Ebisumoto K, Sato Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Ando M, Matsuki T, Nakaguro M, Sato Y, Urano M, Utsumi Y, Kohsaka S, Saotome T, Tada Y. Kawakita D, et al. Among authors: tani k. Ther Adv Med Oncol. 2022 Sep 6;14:17588359221119538. doi: 10.1177/17588359221119538. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36090801 Free PMC article.
1,240 results